INSIGHTS ON PHARMA LOGISTICS
-
Formulation Scientist Shares What Drug Development Teams Should Never Do
Learn why transportation testing is critical to drug development — and how proactive planning can protect your product and investment from costly setbacks.
-
Indiana Pharmaceutical Companies Where Innovation Meets Community
Explore how Indiana’s growing pharmaceutical sector — and globally connected CDMOs — are redefining where innovation in drug development truly happens.
-
Site Transfer Of Tablet Production From Ex-U.S. To Georgia Site
Explore how strategic U.S.-based manufacturing and supply chain diversification can reduce risk, lower costs, and enhance supply reliability for pharmaceutical products.
-
3 Key Bottlenecks In Cell Therapy Supply Chains
Ensure your cell therapy program is prepared for the future by learning how to effectively navigate sourcing, logistics, and manufacturing challenges with confidence.
-
Strengthen Pharmaceutical Supply Chains With A US-Based CDMO6/5/2025
While certain ingredients require sourcing abroad, partnering with a U.S.-based company that owns its manufacturing assets allows for direct oversight of product quality and supply reliability.
-
How To Optimize Labeling In A Pharmaceutical Environment5/29/2025
Accurate, readable pharmaceutical labels are crucial. Learn to navigate considerations like printing, application tolerances, and inspection to select the right machinery for your production environment.
-
The Seamless Path To Market: End-To-End CDMOs As Your Strategic Ally Douglas CDMO5/14/2025
Partner with an experienced end-to-end CDMO to streamline development, reduce risk, and accelerate your drug’s path to market in today’s complex and competitive pharmaceutical landscape.
-
TMT Labeling For Optimized Sample Preparation In Quantitative Proteomics5/13/2025
Leverage the power of Tandem Mass Tags (TMT) quantitative proteomics to gain deep insights into cellular dynamics, disease mechanisms, and drug targeting.
PHARMA LOGISTICS SOLUTIONS
-
Speed-solutions combine value-added services and expertise, delivering an integrated approach, de-risking the supply chain by eliminating the need to transfer to alternative suppliers.
-
Dual sourcing should be implemented to reduce risk and ensure an uninterrupted supply of critical, life-saving therapies. Recent FDA draft guidelines recommend risk management plans to prevent drug product shortages.
-
Expand your pharmaceutical operations in Europe with strategically located facilities offering temperature-controlled storage, streamlined supply chain management, and expert import/export support.
-
Learn about the benefits of a Late Stage Customization approach, including how it can support a leaner, more responsive supply chain, ensuring life-changing therapies reach patients more efficiently.
-
Do you need a CDMO that will fill the gaps in the drug development process and focus on getting patients the treatments they need faster? Our team of experts at Singota is here to collaborate with you, customizing our services to meet your needs and hit your milestones.